Page last updated: 2024-09-03

marimastat and Cancer of Head

marimastat has been researched along with Cancer of Head in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Buchsbaum, DJ; McNally, LR; Rosenthal, EL; Skipper, JB; Wang, W	1
Eccles, S; O-Charoenrat, P; Rhys-Evans, P	1

Other Studies

2 other study(ies) available for marimastat and Cancer of Head

Article	Year
In vivo efficacy of marimastat and chemoradiation in head and neck cancer xenografts. ORL; journal for oto-rhino-laryngology and its related specialties, 2009, Volume: 71, Issue:1 Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Female; Head and Neck Neoplasms; Hydroxamic Acids; Matrix Metalloproteinase Inhibitors; Mice; Mice, Nude; Microcirculation; Neoplasm Transplantation; Neovascularization, Pathologic; Protease Inhibitors; Transplantation, Heterologous; Treatment Outcome	2009
A synthetic matrix metalloproteinase inhibitor prevents squamous carcinoma cell proliferation by interfering with epidermal growth factor receptor autocrine loops. International journal of cancer, 2002, Aug-10, Volume: 100, Issue:5 Topics: Autocrine Communication; Carcinoma, Squamous Cell; Cell Division; Cisplatin; Dose-Response Relationship, Drug; ErbB Receptors; Head and Neck Neoplasms; Humans; Hydroxamic Acids; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Neoplasm Transplantation; Time Factors; Transplantation, Heterologous; Tumor Cells, Cultured	2002

Article

Year

In vivo efficacy of marimastat and chemoradiation in head and neck cancer xenografts.

ORL; journal for oto-rhino-laryngology and its related specialties, 2009, Volume: 71, Issue:1

Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Female; Head and Neck Neoplasms; Hydroxamic Acids; Matrix Metalloproteinase Inhibitors; Mice; Mice, Nude; Microcirculation; Neoplasm Transplantation; Neovascularization, Pathologic; Protease Inhibitors; Transplantation, Heterologous; Treatment Outcome

2009

A synthetic matrix metalloproteinase inhibitor prevents squamous carcinoma cell proliferation by interfering with epidermal growth factor receptor autocrine loops.

International journal of cancer, 2002, Aug-10, Volume: 100, Issue:5

Topics: Autocrine Communication; Carcinoma, Squamous Cell; Cell Division; Cisplatin; Dose-Response Relationship, Drug; ErbB Receptors; Head and Neck Neoplasms; Humans; Hydroxamic Acids; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Neoplasm Transplantation; Time Factors; Transplantation, Heterologous; Tumor Cells, Cultured

2002